Peripheral Blood Mononuclear Cell Proteome Changes in Patients with Myelodysplastic Syndrome
Table 1
Patient characteristics.
Patient
1
2
3
4
5
6
Sex
F
F
F
F
M
F
Age
70
33
69
59
73
65
Hb [g/L]
119
83
91
92
117
104
RBC [1012/L]
3.15
2.47
2.33
2.67
4.29
2.87
WBC [109/L]
2.20
2.81
5.50
4.15
5.10
2.89
PLT [109/L]
184
291
262
211
50
284
NS
1.1
1.91
3.08
2.41
2.3
0.72
Blasts in PB [%]
0
0
0
0
0
0
Blasts in BM [%]
0.4
0.9
3.2
4.8
0.8
3.4
Karyotype
46, XX, inv(9)
46, XX
46, XX, del(5)(q13.2q34)
46, XX, del(5)(q31.q31)
46, XY
46, XX, 1qh+, 46, XX, 1qh+, del(5)(q31)
IPSS
0.5
0
0
0
0
0.5
IPSS-R
Low
Low
Low
Low
Very low
low
WPSS
Low
Low
Low
Low
Intermediate
intermediate
Transfusion [avg./month]
0.50
4.50
3.42
3.25
1.47
2.19
Hb: hemoglobin, RBC: red blood cells, WBC: white blood cells, PLT: platelets, NS: neutrophil segments, PB: peripheral blood, BM: bone marrow, IPSS (-R): International Prognostic Scoring System (-Revised), and WPSS: WHO Classification-Based Prognostic Scoring System.
